Cargando…
Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
We previously observed that inflammatory bowel disease (IBD) may compromise oral host defense, as assessed by decreased salivary levels of immunoglobulin A (IgA) and myeloperoxidase (MPO). Biologic therapy with inhibitors of cytokines or adhesion molecules is increasingly used for patients with IBD....
Autores principales: | Nijakowski, Kacper, Rutkowski, Rafał, Eder, Piotr, Korybalska, Katarzyna, Witowski, Janusz, Surdacka, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708388/ https://www.ncbi.nlm.nih.gov/pubmed/34947940 http://dx.doi.org/10.3390/life11121409 |
Ejemplares similares
-
Potential Salivary Markers for Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis
por: Nijakowski, Kacper, et al.
Publicado: (2021) -
Poor Oral Hygiene and High Levels of Inflammatory Cytokines in Saliva Predict the Risk of Overweight and Obesity
por: Nijakowski, Kacper, et al.
Publicado: (2020) -
Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2020) -
Oral Health Status in Patients with Inflammatory Bowel Diseases: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2021) -
Oral Health in Patients with Inflammatory Bowel Diseases Qualified for Biologic Treatment
por: Nijakowski, Kacper
Publicado: (2022)